Lna Santé S.A (LNA) | Financial Analysis & Statements
Lna Santé S.A. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
1.2B
Shareholders Equity
328.3M
Debt to Equity
3.79
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Lna Santé S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 806.6M | 736.1M | 728.2M | 689.5M | 573.9M |
| Cost of Goods Sold | 85.1M | 76.7M | 105.8M | 111.6M | 92.9M |
| Gross Profit | 721.5M | 659.4M | 622.4M | 577.9M | 481.0M |
| Gross Margin % | 89.5% | 89.6% | 85.5% | 83.8% | 83.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 98.1M | 90.2M | 86.9M | 81.7M | 66.7M |
| Other Operating Expenses | 142.4M | 134.1M | 41.2M | 44.0M | 30.6M |
| Total Operating Expenses | 240.5M | 224.3M | 128.1M | 125.7M | 97.3M |
| Operating Income | 67.3M | 63.3M | 64.2M | 58.9M | 47.1M |
| Operating Margin % | 8.3% | 8.6% | 8.8% | 8.5% | 8.2% |
| Non-Operating Items | |||||
| Interest Income | 1.6M | 1.2M | 364.0K | 1.7M | 267.0K |
| Interest Expense | 29.4M | 27.3M | 21.1M | 20.0M | 19.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 34.1M | 37.3M | 43.2M | 36.3M | 18.6M |
| Income Tax | 11.0M | 13.0M | 15.9M | 14.6M | 10.2M |
| Effective Tax Rate % | 32.3% | 34.9% | 36.9% | 40.2% | 54.7% |
| Net Income | 22.9M | 24.2M | 28.3M | 24.0M | 8.4M |
| Net Margin % | 2.8% | 3.3% | 3.9% | 3.5% | 1.5% |
| Key Metrics | |||||
| EBITDA | 152.4M | 144.7M | 155.5M | 139.1M | 117.8M |
| EPS (Basic) | €2.13 | €2.29 | €2.49 | €2.45 | €0.81 |
| EPS (Diluted) | €2.13 | €2.29 | €2.49 | €2.45 | €0.81 |
| Basic Shares Outstanding | 10225000 | 10222000 | 10359000 | 9579000 | 9582000 |
| Diluted Shares Outstanding | 10225000 | 10222000 | 10359000 | 9579000 | 9582000 |
Income Statement Trend
Lna Santé S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 75.1M | 77.2M | 102.0M | 151.8M | 121.0M |
| Short-term Investments | 47.0K | 415.0K | - | 348.0K | 353.0K |
| Accounts Receivable | 76.3M | 56.1M | 69.5M | 66.5M | 44.8M |
| Inventory | 179.0M | 148.3M | 98.4M | 85.7M | 86.4M |
| Other Current Assets | - | 2.0K | 45.4M | 47.5M | -764.0K |
| Total Current Assets | 374.1M | 333.7M | 318.7M | 354.5M | 306.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 167.0M | 155.4M | 146.5M | 133.6M | 158.8M |
| Goodwill | 715.9M | 701.3M | 702.5M | 682.8M | 672.7M |
| Intangible Assets | 441.1M | 422.6M | 423.3M | 410.5M | 404.1M |
| Long-term Investments | 895.0K | 1.8M | 4.3M | 272.0K | 81.0K |
| Other Non-Current Assets | -2.0K | -1.0K | 2.0K | 1.0K | -3.0K |
| Total Non-Current Assets | 1.2B | 1.2B | 1.2B | 1.2B | 1.2B |
| Total Assets | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 76.5M | 64.9M | 63.2M | 62.4M | 56.1M |
| Short-term Debt | 179.7M | 144.7M | 295.4M | 344.0M | 330.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 34.1M | 30.9M | 89.8M | 84.4M | 131.9M |
| Total Current Liabilities | 412.3M | 354.0M | 496.5M | 549.0M | 561.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 695.5M | 742.0M | 616.1M | 660.6M | 640.7M |
| Deferred Tax Liabilities | 83.5M | 82.0M | 83.3M | 76.9M | 76.9M |
| Other Non-Current Liabilities | 10.9M | 9.3M | 9.2M | 9.0M | 7.8M |
| Total Non-Current Liabilities | 802.3M | 844.7M | 717.8M | 757.8M | 739.3M |
| Total Liabilities | 1.2B | 1.2B | 1.2B | 1.3B | 1.3B |
| Equity | |||||
| Common Stock | 21.4M | 21.4M | 21.4M | 19.5M | 19.4M |
| Retained Earnings | - | 23.4M | 25.8M | 23.5M | 7.8M |
| Treasury Stock | 14.7M | 14.6M | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 323.6M | 308.5M | 298.8M | 223.0M | 195.9M |
| Key Metrics | |||||
| Total Debt | 875.2M | 886.7M | 911.5M | 1.0B | 971.5M |
| Working Capital | -38.2M | -20.2M | -177.8M | -194.5M | -255.9M |
Balance Sheet Composition
Lna Santé S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 22.9M | 24.2M | 28.3M | 24.0M | 8.4M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -23.8M | -38.9M | -18.1M | -43.4M | 56.9M |
| Operating Cash Flow | 22.6M | 11.0M | 19.9M | -2.7M | 82.4M |
| Investing Activities | |||||
| Capital Expenditures | -10.5M | -11.5M | -10.9M | -10.4M | -9.0M |
| Acquisitions | -13.8M | -3.2M | -29.8M | -15.9M | -192.6M |
| Investment Purchases | -512.0K | -287.0K | -259.0K | -814.0K | -1.2M |
| Investment Sales | 405.0K | 415.0K | 329.0K | 2.9M | 1.5M |
| Investing Cash Flow | -24.4M | -14.6M | -40.6M | -24.2M | -201.3M |
| Financing Activities | |||||
| Share Repurchases | 0 | -6.5M | -4.4M | -522.0K | -4.3M |
| Dividends Paid | -6.1M | -5.1M | -4.5M | -1.9M | -4.3M |
| Debt Issuance | 54.6M | 59.6M | 152.5M | 297.0M | 253.9M |
| Debt Repayment | -48.5M | -69.8M | -226.9M | -243.2M | -134.8M |
| Financing Cash Flow | -28.6M | -48.6M | -54.2M | 34.3M | 92.5M |
| Free Cash Flow | 98.3M | 84.6M | 89.9M | 66.0M | 132.7M |
| Net Change in Cash | -30.4M | -52.2M | -74.9M | 7.4M | -26.4M |
Cash Flow Trend
Lna Santé S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.34
Forward P/E
9.36
Price to Book
0.93
Price to Sales
0.33
PEG Ratio
9.36
Profitability Ratios
Profit Margin
2.65%
Operating Margin
7.69%
Return on Equity
6.74%
Return on Assets
1.42%
Financial Health
Current Ratio
0.92
Debt to Equity
2.75
Beta
0.48
Per Share Data
EPS (TTM)
€2.35
Book Value per Share
€31.08
Revenue per Share
€78.89
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LNA | 297.5M | 12.34 | 0.93 | 6.74% | 2.65% | 2.75 |
| Emeis S.A | 2.3B | 0.02 | 1.58 | -19.04% | -5.06% | 598.44 |
| Orpea | 2.2B | 0.10 | - | 71.75% | 79.36% | 4.85 |
| Clariene SE | 1.4B | 9.76 | 0.38 | 0.23% | 0.03% | 200.13 |
| Ramsay Générale de | 1.1B | 34.13 | 0.98 | -2.24% | -0.86% | 343.06 |
Financial data is updated regularly. All figures are in the company's reporting currency.